News & Comment

Five years ago we reported on what we thought was an important clue in the search for understanding the well-documented association between childhood leukemia and EMF exposure. A team based in Shanghai presented evidence that children carrying a genetic variation linked to DNA repair were four times more likely to develop leukemia than those without that genetic marker. We called the finding a “major breakthrough” and predicted, “It simply cannot be ignored.”

We were wrong. So wrong.

What happened next —or rather, what did not happen— sheds light on why EMF research treads water and never moves forward.

Just over a year ago, the Danish Cancer Society (DCS) issued a news advisory with some alarming news: The number of men diagnosed with glioblastoma, the most malignant type of brain cancer, had doubled over the last ten years. Hans Skovgaard Poulsen, the head of neuro-oncology at Copenhagen University Hospital was quoted in the release as saying that this was a “frightening development.”

At the time, Christoffer Johansen, a senior researcher at the DCS told us: “I think the data is true and valid.” And Joachim Schüz, a long time collaborator of Johansen’s at the DCS who is now at the International Agency for Research on Cancer (IARC) in Lyon told Microwave News that the news was “indeed a concern.” He said that he could not explain it. (See our report here.)

After that, there was silence.